This document is a publication of a new patent application filed by Dyno Therapeutics, Inc. The application, identified as US20260083863A1, concerns capsid polypeptides, specifically dependoparvovirus capsid polypeptides, intended for use in delivering therapeutic payloads. The filing date was September 26, 2025, with a publication date of March 26, 2026.

This patent application does not impose any new regulatory obligations or compliance requirements on regulated entities. It represents an intellectual property filing rather than a rule, guidance, or enforcement action. Compliance officers in the pharmaceutical and biotechnology sectors should note this filing as it pertains to novel delivery systems, which may impact future product development and competitive landscapes.